Your session is about to expire
← Back to Search
FAZA PET Scan for Prostate Cancer
N/A
Recruiting
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥ 18 years
Bulky intermediate risk, high risk or metastatic prostate cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial is testing whether a PET scan can measure low levels of oxygen in prostate cancer, which may affect how well treatment works.
Who is the study for?
This trial is for men over 18 with prostate cancer who plan to receive radiotherapy, hormonal therapy, or other systemic treatments. They must be able to consent and lie supine for an hour. It's not for those over 136 kg, taking disulfiram, or with MRI contraindications (unless the target lesion isn't the prostate).Check my eligibility
What is being tested?
The study tests if a PET scan using a tracer called 18F-Fluoroazomycin Arabinoside (18F-FAZA) can detect low oxygen levels in prostate tumors better than current methods. This could influence future treatment strategies.See study design
What are the potential side effects?
While the document doesn't specify side effects of 18F-FAZA, typical PET scan tracers may cause allergic reactions or discomfort at the injection site. The risk of radiation exposure from the scan is also present.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
My prostate cancer is advanced or has spread to other parts.
Select...
My prostate cancer is of the adenocarcinoma type.
Select...
I plan to undergo radiotherapy with or without hormone therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of patients treated with the PET tracer FAZA to image primary tumor hypoxia in patients with prostate cancer prior to treatment with radiotherapy +/- concurrent and adjuvant hormonal therapy
Trial Design
1Treatment groups
Experimental Treatment
Group I: PET FAZA imagingExperimental Treatment1 Intervention
PET FAZA imaging of tumor hypoxia in patients with prostate cancer
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,476 Previous Clinical Trials
485,160 Total Patients Enrolled
63 Trials studying Prostate Cancer
15,380 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot have an MRI if my cancer is in the prostate and needs PET FAZA imaging.I plan to undergo radiotherapy with or without hormone therapy.I am 18 years old or older.My prostate cancer is advanced or has spread to other parts.I have had cancer treatment for the specific area being studied.My prostate cancer is of the adenocarcinoma type.I cannot lie on my back for more than an hour.I am currently taking disulfiram (Antabuse).You weigh more than 136 kilograms.I plan to undergo treatment for prostate cancer as per specific hospital guidelines.
Research Study Groups:
This trial has the following groups:- Group 1: PET FAZA imaging
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment presently recruiting participants?
"From the information available on clinicaltrials.gov, it is evident that this medical study has opened recruitment for participants since April 1st of 2012 and last modified its protocols in October 20th 2022."
Answered by AI
What is the aggregate amount of participants in this research endeavor?
"Affirmative. The information hosted on clinicaltrials.gov ascertains that this trial, which was first posted in April of 2012, is currently recruiting patients for participation. Specifically, 20 subjects are needed from a single medical centre."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger